Meet Dr. Scheiman


Mitchell Scheiman

Dr. Scheiman is board certified in vision therapy as a Fellow in the College of Optometrists in Vision Development (COVD), and is one of only 40 optometrists in the United States that has earned Diplomate status in the American Academy of Optometry (AAO). Dr. Scheiman is currently Dean of Research and a Professor of Optometry and at the Pennsylvania College of Optometry at Salus University where he has been a faculty member for over 30 years. He teaches course on binocular vision, amblyopia, and vision therapy. He has been in private practice in since 1987, specializing in vision therapy and children’s vision disorders.

In the last 25 years he has spent the majority of his professional time as a researcher involved in randomized clinical trials. He has been a principal investigator for the Correction of Myopia Evaluation Trial designed to investigate treatments to slow the progression of myopia in children. He was the Study Chair of the seminal Convergence Insufficiency Treatment Trial that was completed in 2008 investigating the effectiveness of treatment for convergence insufficiency, a NIH funded, randomized multicenter clinical trial that was published in 2008. This study is the largest and most comprehensive study done to date on vision therapy, and conclusively showed that office based vision therapy is the treatment of choice for convergence insufficiency. Convergence insufficiency is the most common eye muscle disorder, affecting 3-5% of children and adults.He is currently Study Chair of the new CITT-ART study investigating the effect of vision therapy for convergence insufficiency on reading and attention. He has published over 170 journal articles and has written 4 textbooks.